Imunon IMNN
NASDAQ IMNN
$1.37 +0.05 (+3.82%)
As of: Oct 2, 2026 · 11:54 AM EDT

Imunon (IMNN) Long-Term Investments (2021 - 2023)

Updated

Imunon (IMNN) reported Long-Term Investments of $3.75 million for Q1 2023, down 37.5% from $6 million a year earlier and down 16.7% from the prior quarter.

Analysis

Imunon (IMNN) Long-Term Investments (2021 - 2023) Analysis & Trends

At the end of FY2022, Imunon posted Long-Term Investments of $4.5 million, down 25.0% from FY2021.

  • By year, Long-Term Investments came in at $6 million in FY2021.
  • The Q1 2023 figure ranks as the lowest quarterly Long-Term Investments in data going back to Q2 2021.
  • Per Business Quant data, the three quarters before Q1 2023 came in at $4.5 million (Q4 2022), $6 million (Q3 2022) and $6 million (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Imunon 6.02 Mn 6.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 3.75 Mn
Dec 31, 2022 4.50 Mn
Sep 30, 2022 6.00 Mn
Jun 30, 2022 6.00 Mn
Mar 31, 2022 6.00 Mn
Dec 31, 2021 6.00 Mn
Sep 30, 2021 6.00 Mn
Jun 30, 2021 6.00 Mn
API Access

Imunon Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=IMNN&period=max&api_key=YOUR_API_KEY